Nordhealth AS – Stabilization measures taken
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.
Reference is made to the stock exchange announcement by Nordhealth AS (“Nordhealth” or the “Company”) on 3 June 2021 where the Company announced the beginning of the stabilization period following the private placement of new shares in the Company (the “Private Placement”) and the subsequent admission to trading on Euronext Growth Oslo.
The Company has received notification that Carnegie AS, acting as stabilization manager in the Private Placement, has taken the stabilization measures set out in the attached notifications with respect to the shares of the Company.
For further information, please contact:
Charles MacBain, CEO
+44 75 3903 2200
Valter Pasanen, CFO
+358 50 560 9286
Nordhealth is a cloud-based healthcare SaaS company whose mission is to redefine digital healthcare. The Company’s products empower healthcare professionals to improve patient care, increase efficiency and expand their business. Since 2005, the Company has acquired and built cloud-based software for veterinary and therapeutic professionals and their patients, and now serves more than 30,000 professionals across 7,000 clinics and hospitals located in over 25 countries.
Headquartered in Espoo, Finland, Nordhealth has a solid footprint in the Nordic region and a growing presence internationally, with more than 240 employees working either remotely or from offices (collaboration hubs), serving a global customer base. Visit the company’s website at nordhealth.com.